These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 39122918)

  • 1. Effects of chronic naltrexone treatment on relapse-related behavior and neural responses to fentanyl in awake nonhuman primates.
    Withey SL; Deshpande HU; Cao L; Bergman J; Kohut SJ
    Psychopharmacology (Berl); 2024 Nov; 241(11):2289-2302. PubMed ID: 39122918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effects of Chronic Naltrexone on Reinstatement of Opioid-Induced Drug-Seeking Behavior and Antinociception.
    Withey SL; Bergman J; Paronis CA
    J Pharmacol Exp Ther; 2024 Mar; 389(1):5-14. PubMed ID: 37699710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of Daily Methocinnamox Treatment on Fentanyl Self-Administration in Rhesus Monkeys.
    Maguire DR; France CP
    J Pharmacol Exp Ther; 2022 Aug; 382(2):181-187. PubMed ID: 35643857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of the Positive-Reinforcing Effects of Ultra-Potent Fentanyl Analogs, Along with Those of Fentanyl and Heroin, During Daily Treatment with Methocinnamox in Rhesus Monkeys.
    Gerak LR; France CP
    J Pharmacol Exp Ther; 2023 Mar; 384(3):363-371. PubMed ID: 36575032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugate vaccine produces long-lasting attenuation of fentanyl vs. food choice and blocks expression of opioid withdrawal-induced increases in fentanyl choice in rats.
    Townsend EA; Blake S; Faunce KE; Hwang CS; Natori Y; Zhou B; Bremer PT; Janda KD; Banks ML
    Neuropsychopharmacology; 2019 Sep; 44(10):1681-1689. PubMed ID: 31043682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of extended-release naltrexone on the brain response to drug-related stimuli in patients with opioid use disorder.
    Shi Z; Wang AL; Jagannathan K; Fairchild VP; O'Brien CP; Childress AR; Langleben DD
    J Psychiatry Neurosci; 2018 Jul; 43(4):254-261. PubMed ID: 29947607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for kappa-, but not mu-opioid, receptor activation in acute food deprivation-induced reinstatement of heroin seeking in rats.
    Sedki F; Eigenmann K; Gelinas J; Schouela N; Courchesne S; Shalev U
    Addict Biol; 2015 May; 20(3):423-32. PubMed ID: 24725195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential involvement of mu-opioid receptors in the rostral versus caudal nucleus accumbens in the reinforcing effects of heroin in rats: evidence from focal injections of beta-funaltrexamine.
    Martin TJ; Kim SA; Lyupina Y; Smith JE
    Psychopharmacology (Berl); 2002 May; 161(2):152-9. PubMed ID: 11981595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A method for conducting functional MRI studies in alert nonhuman primates: initial results with opioid agonists in male cynomolgus monkeys.
    Kaufman MJ; Janes AC; Frederick Bd; Brimson-Théberge M; Tong Y; McWilliams SB; Bear A; Gillis TE; Schrode KM; Renshaw PF; Negus SS
    Exp Clin Psychopharmacol; 2013 Aug; 21(4):323-31. PubMed ID: 23773004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fentanyl-induced changes in brain activity in awake nonhuman primates at 9.4 Tesla.
    Withey SL; Cao L; de Moura FB; Cayetano KR; Rohan ML; Bergman J; Kohut SJ
    Brain Imaging Behav; 2022 Aug; 16(4):1684-1694. PubMed ID: 35226333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative Reinforcers Enhance the Effects of Opioid Antagonists, but Not Agonists, on Oxycodone Choice Self-Administration in Nonhuman Primates.
    de Moura FB; Kohut SJ
    J Pharmacol Exp Ther; 2024 Oct; 391(2):301-307. PubMed ID: 39284627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinstatement of cocaine-seeking behavior in rats is attenuated following repeated treatment with the opioid receptor antagonist naltrexone.
    Gerrits MA; Kuzmin AV; van Ree JM
    Eur Neuropsychopharmacol; 2005 May; 15(3):297-303. PubMed ID: 15820419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute and repeated treatment with methocinnamox, a mu opioid receptor antagonist, on fentanyl self-administration in rhesus monkeys.
    Maguire DR; Gerak LR; Sanchez JJ; Javors MA; Disney A; Husbands SM; France CP
    Neuropsychopharmacology; 2020 Nov; 45(12):1986-1993. PubMed ID: 32375158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of nucleus accumbens μ-opioid and adenosine 2A receptor stimulation and blockade on instrumental learning.
    Clissold KA; Pratt WE
    Behav Brain Res; 2014 Nov; 274():84-94. PubMed ID: 25101542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fentanyl increases dopamine release in rat nucleus accumbens: involvement of mesolimbic mu- and delta-2-opioid receptors.
    Yoshida Y; Koide S; Hirose N; Takada K; Tomiyama K; Koshikawa N; Cools AR
    Neuroscience; 1999; 92(4):1357-65. PubMed ID: 10426490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OREX-1019: A Novel Treatment of Opioid Use Disorder and Relapse Prevention.
    Maguire DR; Gerak LR; Cami-Kobeci G; Husbands SM; France CP; Belli B; Flynn P
    J Pharmacol Exp Ther; 2020 Feb; 372(2):205-215. PubMed ID: 31748404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medial prefrontal neuroplasticity during extended-release naltrexone treatment of opioid use disorder - a longitudinal structural magnetic resonance imaging study.
    Shi Z; Li X; Todaro DR; Cao W; Lynch KG; Detre JA; Loughead J; Langleben DD; Wiers CE
    Transl Psychiatry; 2024 Sep; 14(1):360. PubMed ID: 39237534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the cannabinoid CB
    AlKhelb D; Kirunda A; Ho TC; Makriyannis A; Desai RI
    Drug Alcohol Depend; 2022 Nov; 240():109646. PubMed ID: 36191533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of kappa opioid receptors in stress-induced reinstatement of alcohol seeking in rats.
    Funk D; Coen K; Lê AD
    Brain Behav; 2014 May; 4(3):356-67. PubMed ID: 24944865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel dual agonist of glucagon-like peptide-1 receptors and neuropeptide Y2 receptors attenuates fentanyl taking and seeking in male rats.
    Zhang Y; Rahematpura S; Ragnini KH; Moreno A; Stecyk KS; Kahng MW; Milliken BT; Hayes MR; Doyle RP; Schmidt HD
    Neuropharmacology; 2021 Jul; 192():108599. PubMed ID: 33965397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.